Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor

Chemistry and Biology

Volumn 2, Issue 10, 1995, Pages 683-695

  Green, Louis S ^a   Jellinek, Derek ^a   Bell, Carol ^a   Beebe, Laurie A ^a   Feistner, Bruce D ^a   Gill, Stanley C ^a   Jucker, Fiona M ^a   Janjić, Nebojša ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

2 amino 2 deoxypyrimidine nucleotide RNA; angiogenesis; combinatorial libraries; in vitro evolution; nuclease resistant oligonucleotides

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; LIGAND; LYMPHOKINE; NUCLEIC ACID; OLIGONUCLEOTIDE; PEPTIDE LIBRARY; PURINE DERIVATIVE; RECOMBINANT PROTEIN; RIBONUCLEASE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ARTICLE; CHEMISTRY; HUMAN; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE; NUCLEOTIDE SEQUENCE; PHYSICAL CHEMISTRY; RAT; SYNTHESIS; URINE;

ANIMALS; BASE SEQUENCE; CHEMISTRY, PHYSICAL; ENDOTHELIAL GROWTH FACTORS; HUMANS; LIGANDS; LYMPHOKINES; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEIC ACIDS; OLIGONUCLEOTIDES; PEPTIDE LIBRARY; PURINES; RATS; RECOMBINANT PROTEINS; RIBONUCLEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0029379767     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/1074-5521(95)90032-2     Document Type: Article

References (58)

1. Tumor angiogenesis: therapeutic implications
2. Angiogenesis in cancer, vascular and other diesease
3. The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma
4. Induction of fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products
5. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
6. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
7. Human vascular permeability factor. Isolation from U937 cells
8. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
9. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
10. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line (GS-9L)
11. Vascular endothelial growth factor is a secreted angiogenic mitogen
12. Vascular permeability factor, an endothelial cell mitogen related to platelet-derived growth factor
13. The vascular endothelial growth factor family: identification of a fourth species and characterization of alternative splicing of RNA
14. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
15. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
16. Identification of a new endothelial cell growth factor receptor tyrosine kinase
17. High affinity vascular endothelial growth factor binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
18. Vascular endothelial growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF binding sites
19. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
20. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
21. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
22. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
23. Vascular permeability factor (VPF, VEGF) in tumor biology
24. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels
25. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
26. Vascular endothelial growth factor/vascular permeability factor is detectable in sera of tumor-bearing mice and cancer patients
27. Oligonucleotides as research, diagnostic, and therapeutic agents
28. Diversity of oligonucleotide functions
29. Modified RNA sequence pools for in vitro selection
30. The application of a modified nucleotide in aptamer selection novel thrombin aptamers containing 5-(1-pentynyl)-2′-deoxyuridine
31. Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor
32. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor
33. The selection of high affinity RNA ligands to the bacteriophage R17 coat protein
34. Alignment editing and identification of consensus secondary structures for nucleic acid sequences. Interactive use of dot matrix representations
35. Similarity and homology
36. Kinetic characterization of ribonuclease-resistant 2′-modified hammerhead ribozymes
37. Polynucleotides containing 2′-amino-2′-deoxyribose and 2′-azido-2′-deoxyribose
38. Synthesis and interactions of oligodeoxyribonucleotides containing 2′-amino-2′-deoxyuridine
39. Oligonucleotide duplexes containing 2′-amino-2′deoxycytidines: thermal stability and chemical reactivity
40. Synthesis and hybridization studies on two complementary nona(2′-O-methyl)ribonucleotides
41. Oligodeoxynucleotides containing 2′-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes
42. Information content of binding sites on nucleotide sequences
43. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding
44. Comprehensive chemical modification interference analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase
45. Measurement and magnitude of enzymatic rate constants
46. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA
47. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
48. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors
49. Platelet-derived growth factor
50. Determination of RNA-protein contacts using thiophosphate substitutions
51. An RNA mutation that increases the affinity of an RNA-protein interaction
52. Maturation of B lymphocytes and expression of immunoglobulin genes
53. Efficient synthesis of 2′-amino-2′deoxypyrimidine 5′-triphosphates
54. Polymer support oligonucleotide synthesis XVIII: use of β-cyanoethyl-N, N-dialkylamino-N-morpholino phosphoramidite of deoxynucleotides for the synthesis of DNA fragments
55. Chemical synthesis of biologically active oligoribonucleotides using β-cyanoethyl protected ribonucleotide phosphoramidites
56. Facile synthesis of 2′-amino-2′-deoxyribofuranosyl purines
57. Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates
58. A new method for water suppression in the protein NMR spectra of aqueous solutions